Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
Treating ER+/HER2− ESR1m mBC: EMERALD Subgroup Analyses in Clinical Cancer Research
Medical Industry FeatureTreating ER+/HER2− ESR1m mBC: EMERALD Subgroup Analyses in Clinical Cancer Research
Asparaginase Therapy in Patients with ALL/LBL
Medical Industry FeatureAsparaginase Therapy in Patients with ALL/LBL
Navigating a Positive MCED Test and Negative Diagnostic Workup: Real-World Data
Medical Industry FeatureNavigating a Positive MCED Test and Negative Diagnostic Workup: Real-World Data
Examining a Therapeutic Modality for 2L+ mNSCLC
Medical Industry FeatureExamining a Therapeutic Modality for 2L+ mNSCLC
The CLL Patient Journey: From Diagnosis to Initial Treatment
Medical Industry FeatureThe CLL Patient Journey: From Diagnosis to Initial Treatment
Navigating CLL Treatment: Patient Preferences and Shared Decision-Making
Medical Industry FeatureNavigating CLL Treatment: Patient Preferences and Shared Decision-Making
Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
Project Oncology®Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
On the Frontlines of Metastatic Breast CancerBalancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
On the Frontlines of Metastatic Breast CancerNavigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
Advances in Chronic GVHD Care: Insights from the AGAVE-201 Trial
Project Oncology®Advances in Chronic GVHD Care: Insights from the AGAVE-201 Trial
Targeting CD123 in AML: The Latest Therapeutic Advancements
Project Oncology®Targeting CD123 in AML: The Latest Therapeutic Advancements
Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Project Oncology®Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Project Oncology®HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Antibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management
CME/CEAntibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management
Reviewing the Latest Bladder Cancer Practice Guidelines
MinuteCE®Reviewing the Latest Bladder Cancer Practice Guidelines
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
MinuteCE®Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
- 04/26/2025
- 04/24/2025
- 04/23/2025
- 04/23/2025
- 04/22/2025
- 04/22/2025